These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10384967)

  • 21. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.
    Auwerx J; Van Nieuwenhove J; Rodríguez-Barrios F; de Castro S; Velázquez S; Ceccherini-Silberstein F; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
    FEBS Lett; 2005 Apr; 579(11):2294-300. PubMed ID: 15848161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroxine-derivatives of lipopeptides: bifunctional dimerization inhibitors of human immunodeficiency virus-1 protease.
    Dumond J; Boggetto N; Schramm HJ; Schramm W; Takahashi M; Reboud-Ravaux M
    Biochem Pharmacol; 2003 Apr; 65(7):1097-102. PubMed ID: 12663045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent inhibition of drug-resistant HIV protease variants by monoclonal antibodies.
    Bartonová V; Král V; Sieglová I; Brynda J; Fábry M; Horejsí M; Kozísek M; Sasková KG; Konvalinka J; Sedlácek J; Rezácová P
    Antiviral Res; 2008 Jun; 78(3):275-7. PubMed ID: 18329737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peptide inhibitor of HIV-1 protease using alpha, beta- dehydro residues: a structure based computer model.
    Siddiqui MI; Kataria S; Ahuja V; Rao GS
    Indian J Biochem Biophys; 2001; 38(1-2):90-5. PubMed ID: 11563339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive inhibitors of the HIV-1 protease.
    Ohtaka H; Freire E
    Prog Biophys Mol Biol; 2005 Jun; 88(2):193-208. PubMed ID: 15572155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative studies on inhibitors of HIV protease: a target for drug design.
    Jayaraman S; Shah K
    In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the Vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease.
    Adekale MA; Cane PA; McCrae MA
    J Med Virol; 2005 Feb; 75(2):195-201. PubMed ID: 15602725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of low molecular weight HIV-1 protease dimerization inhibitors.
    Hwang YS; Chmielewski J
    J Med Chem; 2005 Mar; 48(6):2239-42. PubMed ID: 15771466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yeast two-hybrid assay for examining human immunodeficiency virus protease heterodimer formation with dominant-negative inhibitors and multidrug-resistant variants.
    Todd S; Laboissière MC; Craik CS
    Anal Biochem; 2000 Jan; 277(2):247-53. PubMed ID: 10625514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoprocessing of HIV-1 protease is tightly coupled to protein folding.
    Louis JM; Clore GM; Gronenborn AM
    Nat Struct Biol; 1999 Sep; 6(9):868-75. PubMed ID: 10467100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid synthesis and in situ screening of potent HIV-1 protease dimerization inhibitors.
    Lee SG; Chmielewski J
    Chem Biol; 2006 Apr; 13(4):421-6. PubMed ID: 16632254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients.
    Malet I; Wirden M; Derache A; Simon A; Katlama C; Calvez V; Marcelin AG
    AIDS; 2007 Apr; 21(7):871-3. PubMed ID: 17415044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
    Nakatani S; Hidaka K; Ami E; Nakahara K; Sato A; Nguyen JT; Hamada Y; Hori Y; Ohnishi N; Nagai A; Kimura T; Hayashi Y; Kiso Y
    J Med Chem; 2008 May; 51(10):2992-3004. PubMed ID: 18426195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The folding and dimerization of HIV-1 protease: evidence for a stable monomer from simulations.
    Levy Y; Caflisch A; Onuchic JN; Wolynes PG
    J Mol Biol; 2004 Jun; 340(1):67-79. PubMed ID: 15184023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular tongs containing amino acid mimetic fragments: new inhibitors of wild-type and mutated HIV-1 protease dimerization.
    Bannwarth L; Kessler A; Pèthe S; Collinet B; Merabet N; Boggetto N; Sicsic S; Reboud-Ravaux M; Ongeri S
    J Med Chem; 2006 Jul; 49(15):4657-64. PubMed ID: 16854071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
    Frecer V; Berti F; Benedetti F; Miertus S
    J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
    Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
    Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1, 2, 3-current ways to fight HIV.
    Vazquez E
    Posit Aware; 1998; 9(6):31-3. PubMed ID: 11366478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A unidirectional crosslinking strategy for HIV-1 protease dimerization inhibitors.
    Hwang YS; Chmielewski J
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4297-300. PubMed ID: 15261290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New drugs for old.
    Winston A; Stebbing J
    J HIV Ther; 2005 Mar; 10(1):11-6. PubMed ID: 15951729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.